SciSparc unit NeuroThera Labs validates quantum sampling workflow for clinical trial analytics on S&P 500 firm's hybrid platform
- NeuroThera Labs is a majority-owned subsidiary of SciSparc focused on clinical trial data analytics.
- The validated workflow is proprietary and designed for use on hybrid quantum-classical computing architectures.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.